One of the benefits of decoding the human genome is the ability to create a personalized medical forecast for every individual by means of pharmacogenetics screening. The way the patient respond to certain medication is influenced by his genetic profile, which can explain the high level of undesirable side effects to medication and the ineffectiveness of treatments.
With the support of its genotyping technology (TaqMan and Pyrosequencing platforms) CBM offers its pharmacogenetics expertise to give a pharmacogenetic service willing to give a personalized anti-tumor treatment to their patients. With this knowledge, preventative measures and tailored therapy can be carried out.
This genetic testing can be done on a simple mouth swab that could be stored at room temperature and sent to our laboratory by mail.
- Genomic DNA extraction from the biological sample
- Genotyping of all the common genetic variants involved in the pharmacological outcome of the requested chemo/radiotherapeutic treatment
- A detailed report on the potential risk/benefit of the pharmacological treatment based on the patient genetic profile
- Possibility to further discuss the results of the test with our pharmacogenetists